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Objectives: To determine the genetic composition of the ﬁrst VanA-type plasmid (pIP816) reported, which was
isolated from a clinical Enterococcus faecium (BM4147) strain in France in 1986, and to reveal the genetic units
responsible for the dissemination of the vanA gene cluster by comparisons with current, published and
additionally generated vanA-spanning plasmid sequences obtained from a heterogeneous E. faecium strain
collection (n¼28).
Methods: Plasmid sequences were produced by shotgun sequencing using ABI dye chemistry and primer
walking, and were subsequently annotated. Comparative sequence analysis of the vanA region was done
with published plasmids, with a partial vanA plasmid (pVEF4) reported here and to .140 kb of sequence
obtained from a collection of vanA-harbouring plasmid fragments.
Results: Bioinformatic analyses revealed that pIP816 from 1986 and contemporary vanA plasmids shared a
conserved genetic fragment of 25 kb, spanning the 10.85 kb vanA cluster encoded by Tn1546, and that the
larger unit is present in both clinical and animal complexes of E. faecium. A new group II intron in pVEF4
was characterized.
Conclusions: Comparative DNA analyses suggest that Tn1546 disseminates in and between clonal complexes of
E. faecium as part of a larger genetic unit, possibly as a composite transposon ﬂanked by IS1216 elements.
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Introduction
The mammalian gut-dwelling genus Enterococcus, particularly
Enterococcus faecium and Enterococcus faecalis, have rapidly
emerged as troublesome nosocomial pathogens. This has pri-
marily occurred due to a combination of favourable antibiotic
selective pressures with respect to intrinsic resistances,
1 as well
as an inherent propensity for inter- and intraspecies gene trans-
fer
2 (for an excellent review, see Willems and Bonten
3). Plasmids
and transposons have been shown to play key roles in the
acquisition and dissemination of drug resistance in the genus
Enterococcus.
4–12 The emergence and rapid spread of
glycopeptide-resistant E. faecium (GREF) has been a particular
challenge, as there are few remaining options for antimicrobial
treatment.
1 The ﬁrst clinical GREF was discovered in France in
1986 and harboured the VanA-type plasmid pIP816.
13 Sub-
sequently, nosocomial GREF has been reported worldwide, with
an increasing prevalence in the USA in particular,
14 but also in
European countries in recent years (http://www.rivm.nl/earss/).
In addition to the limited options for GREF treatment, there is
also a concern for further horizontal transfer of glycopeptide
resistance determinants into more pathogenic Gram-positive
species, such as Staphylococcus aureus and Clostridium difﬁcile.
15
This is underscored by nine cases of VanA-type vancomycin-
resistant S. aureus isolated in the USA since 2002, and the evi-
dence for an enterococcal origin as well as plasmid-mediated
transfer is compelling.
16 More sequence information on VanA-
type plasmids from different reservoirs is necessary to clarify
their role and function in the maintenance and dissemination
of glycopeptide resistance determinants in Enterococcus spp.
The use of the glycopeptide avoparcin as an animal growth
promoter in European countries provided the opportunity for a
build-up of a community reservoir of GREF.
17,18 Avoparcin resist-
ance mediates cross-resistance to vancomycin, a clinically
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19 and avoparcin was thus prohibited for
further use in animal husbandry. However, diverse GREF strains
have persisted on farms several years after the ban.
20–22 The
persistent GREF populations carry vanA plasmids harbouring
the non-conjugative transposon Tn1546.
21,23 Tn1546 is also fre-
quently located on plasmids in GREF strains isolated from hospi-
talized patients and healthy volunteers in the community.
24–26
The presence of conserved Tn1546 elements in genomically het-
erogeneous E. faecium isolates from various environments
suggests the spread of resistance by horizontal gene transfer.
27
We have previously reported the presence of a common
372 bp DNA stretch immediately ﬂanking Tn1546 in a polyclonal
E. faecium population.
21,22 It was hypothesized that the vanA
gene cluster (Tn1546) disseminates as a larger genetic unit
than the transposon, but smaller than a plasmid, due to the het-
erogeneous plasmid sizes and restriction patterns observed in
the strain collection examined.
The aim of this study was to increase the knowledge on enter-
ococcal plasmid population genetics and dynamics, with an
emphasis on E. faecium vanA plasmids. We present: (i) the com-
plete sequence of the Tn1546-containing pIP816,
13 ﬁrst isolated
in France 1986; (ii) a partial sequence of the Tn1546-containing
E. faecium pVEF4, isolated from a Norwegian poultry farm pre-
viously exposed to avoparcin; and (iii) 28 Tn1546-containing
genetic fragments ampliﬁed and sequenced from diverse
E. faecium strains. Comparative analyses suggest that a genetic
unit larger than the 10.85 kbp Tn1546 has facilitated the horizon-
tal spread of plasmid-encoded glycopeptide resistance between
different E. faecium clonal lineages. Sequence data indicate hori-
zontal dissemination as a composite transposon. Lastly, a novel
enterococcal group II intron was identiﬁed within the composite
transposon of several of the vanA plasmids and is functionally
analysed here. Group II introns are ribozymes that catalyse
their own excision and ligation of ﬂanking exon sequences.
28
Materials and methods
Bacterial strains and plasmids
The bacterial strains and plasmids, and their relevant characteristics are
given in Table 1. All strains were grown at 378C using brain heart infusion
(BHI) agar or broth (Fluka BioChemika). The VanA-positive strains of
E. faecium were grown in media supplemented with 10 mg/Lvancomycin
(Sigma).
DNA sequencing and analyses of pIP816 and pVEF4
Plasmid DNA was isolated by alkaline lysis, as previously described.
21,29
The fragmentation of plasmid pIP816 and subsequent cloning in
Escherichia coli was done with the TOPO shotgun subcloning kit, as
described by the manufacturer (Invitrogen). Plasmid DNA was puriﬁed
prior to sequencing with the Perfectprep Plasmid 96 Vac system (Eppen-
dorf). Custom primers (Sigma–Genosys) were used in PCRs for gap
closure. The sequencing was done using ABI BigDye terminator chemistry
(Perkin–Elmer Applied Biosystems Inc.) with ABI3130XL automated
sequencers. Assembly of the sequence data was done using the Staden
package
30 and Phrap (http://www.phrap.org/). The initial plasmid sequence
of pIP816 was presented as a poster at the International Symposium on
Plasmid Biology, 2006.
31 The draft contig sequences of pVEF4 were pro-
vided by Macrogen, Korea, using BigDye chemistry and with a sequence
depth of .14× coverage. Further extensive primer walk and gap closure
experiments were done; however, we did not succeed in plasmid
closure. Artemis was used to annotate the nucleotide sequence of
pIP816 and pVEF4.
32 GLIMMER was used to predict coding sequences
(CDSs)
33 that were checked manually by correlation scores of the open
reading frames with ≥50 amino acids. Sequence similarity searches by
FASTA and BLASTP reﬁned the predictions.
34,35
Five complete E. faecium vanA plasmids were published in the
nucleotide databases EMBL, GenBank and DDBJ as of May 2010
(Table 2). These plasmids as well as the partial pVEF4 sequence were
analysed according to genetic composition and synteny using the
Artemis Comparison Tool.
32
PCR ampliﬁcation and DNA sequencing of fragments
of vanA plasmids
The DNA regions ﬂanking the vanA gene cluster were also determined for
28 different vanA plasmids isolated from genomically diverse E. faecium
strains of human or animal origin (Table 1). Isolated plasmid DNA was
treated with PlasmidSafe DNase (Epicentre), and subsequently digested
separately with PstI, EcoRI and BamHI according to the manufacturer’s
protocol (New England BioLabs), and separated by agarose gel electro-
phoresis. Undigested plasmid DNA was used in PCR assays, where rTth
DNA polymerase (GeneAmp XL PCR Kit, Applied Biosystems) and Jump-
Start Taq DNA Polymerase (JumpStart ReadyMix Taq, Sigma) were used
according to the manufacturers’ protocols to amplify DNA fragments
up- and downstream of Tn1546 using the primers speciﬁed in Table 3.
Four PCR assays with the following primer combinations were
used: PCF1 and PCF2 (7.1 kb amplicon); PCF1 and PCF3 (7.6 kb amplicon);
PCF1 and PCF4 (6.0 kb amplicon); and PCF5 and PCF6 (1.2 kb amplicon).
The PCR cycling parameters used in the ampliﬁcations of long fragments
were initial denaturation at 948C for 3 min followed by 25 cycles of 948C
for 1 min and 648C for 11 min, and a ﬁnal extension at 728C for 10 min.
For the JumpStart Taq PCRs, the cycling parameters were denaturation at
948C for 2 min followed by 30 cycles of denaturation (948C, 30 s), anneal-
ing (588C, 30 s) and extension (728C, 1 min 30 s), and a ﬁnal extension at
728C for 5 min. PCR products were analysed by agarose gel electrophor-
esis. Positive PCR products were conﬁrmed by sequencing, as described
above. Custom sequencing primers were used for primer walking when
necessary (primers not given).
Group II intron characterization
Intron RNA secondary structure predictions were performed by the mfold
server v. 3.2
36,37 and classiﬁcation was based on group II intron consen-
sus structures.
38 The broader distribution of the group II intron, and its
presence in the topoisomerase I gene, was investigated among the 28
vanA plasmids isolated from the E. faecium strain collection (Table 1)
by PCR with the primers giiF/giiR3 and ip3F/giiR7 (Table 3) and JumpStart
Taq DNA Polymerase, as described above. RNA extraction and subsequent
RT–PCR were used to conﬁrm intron splicing. From overnight cultures of
E. faecium 399/S99/A7 and E. faecium 399/F98/A4, 10 mL of each
culture was transferred to 10 mL fresh BHI broth and further cultured
to a density of  1×10
8 cells. The cell cultures were treated with RNAlater
(Ambion), according to the supplier’s protocol, followed by total RNA
extraction by QIAGEN RNeasy Mini kit and DNaseI treatment with
QIAGEN RNase-Free DNase (QIAGEN). RNA extracts were veriﬁed free of
DNA contamination by using 1 mg of total RNA as template in a PCR
with the DyNAzyme II DNA polymerase (Finnzymes). cDNA syntheses
were done using the SuperScript III enzyme (Invitrogen) on  1 mgo f
total RNA as template and, in other respects, according to protocol.
RT–PCRs were carried out with the primers given in Table 3. The
RT–PCR cycling parameters used were denaturation at 948C for 2 min fol-
lowed by 30 PCR cycles of 948C for 45 s, 588C for 30 s and 728C for 30 s to
1.5 min (depending on the length of the product), and a ﬁnal extension at
728C for 5 min. The products were analysed by agarose gel electrophoresis
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the PCR fragments of ligated exons were sequenced.
Results
General features of the VanA-type plasmids pIP816 and
pVEF4
The complete sequence of the plasmid pIP816 was determined
and a partial sequence of pVEF4 is presented. pIP816 was
extracted from the ﬁrst glycopeptide-resistant E. faecium
reported (strain BM4147) and was sampled from a patient with
leukaemia in France in 1986.
13 pVEF4 was isolated from an
E. faecium strain (399/F98/A4) sampled from poultry in 1998
on a Norwegian poultry farm where avoparcin was previously
used as a growth promoter.
21 pIP816 (EMBL accession
no. AM932524) is 34616 bp in size, and has 36 CDSs and an
average G+C content of 36.9% (Figure 1 and Table 4). The
partial sequence of pVEF4 (EMBL accession no. FN424376) is
44443 bp in length, and has a G+C content of 36.2% and
46 CDSs (Figure 1 and Table 5). Repeated attempts were made
to achieve gap closure, but we did not succeed. We do,
however, include the 44.4 kb partial, single sequence in this
study, because it provides valuable additional information for
the analysis of Tn1546 junctions (see below) as well as on the
composition of the overall E. faecium plasmid pool. Similarity
searches identiﬁed 31 and 39 CDSs with known or predicted
functions in pIP816 and in pVEF4, respectively. pIP816 and
Table 1. The vanA-containing E. faecium strains used in this study and their characteristics
Strain Geographical origin Sample source Epidemiology
a MLST/CC
b PFGE Reference/source
c
399/F99/H8 Norway human cs 195/CC9 7 21
399/F99/A9 Norway animal cs 241/CC9 10A 21
399/S99/A7 Norway animal cs ND 11 21
BM4147 France human ci 95/CC22 ND 13
399/F98/A4 Norway animal cs ND 5 21
BM4147-1 France — — 95/CC22 — 13
399/F98/A1 Norway animal cs ND 9 21
399/F99/A8 Norway animal cs 9/CC9 11 21
64/F98/H2 Norway human cs 242/ND 14 21
356/98/H Norway human cs ND ND 22
31/F01/H Norway human cs ND ND 22
399/F99/A10 Norway animal cs 310/CC9 5A 21
64/F99/A6 Norway animal cs 146/ND 15 21
64/F99/H6 Norway human cs 246/CC9 17 21
58/F01/H Norway human cs ND ND 22
399/F98/H2 Norway human cs 8/CC9 2 21
399/S99/H6 Norway human cs 2/CC1 6 21
64/F98/H1 Norway human cs 48/CC9 13 21
64/F98/A3 Norway animal cs 8/CC9 20 21
K8-61 Norway human ci ND ND K-res
c
64/F98/A2 Norway animal cs 195/CC9 19 21
TUH32-76 Portugal human ci 132/CC17 ND 57
32/F02/H Norway human cs ND ND 22
K9-72 Norway human ci ND ND K-res
c
64/S99/A5 Norway animal cs ND 21 21
TUH2-8 Sweden human ci ND ND K-res
c
TUH32-64 UK human ho 18/CC17 ND 57
TUH32-71 Netherlands human ho 16/CC17 ND 57
TUH32-72 USA human ho 17/CC17 ND 57
TUH32-74 USA human ho 20/ND ND 57
TUH32-77 Portugal human ci 125/ND ND 57
TUH32-78 Netherlands human ci 21/CC9 ND 57
TUH32-79 Netherlands human hs 5/CC5 ND 57
TUH43-7 Norway human cs ND ND 22
MLST, multilocus sequence type; PFGE, pulsed-ﬁeld gel electrophoresis; CC, clonal complex; ND, not determined.
aci, clinical isolate; cs, community survey; ho, hospital outbreak; hs, hospital survey.
bCC, clonal complex, extracted from references.
22,45,48,49,56
cK-res, Reference Centre for Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North
Norway.
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that the Tn1546 transposon has transposed into, as well as
genes involved in plasmid partitioning, a resolvase, truncated
transposases and a hypothetical protein (Figure 1). A topoisom-
erase is also present on both plasmids, but in pVEF4 a group II
intron with an intron-encoding protein (CDS19) was identiﬁed
inserted into the topo gene (see below). The entire Tn1546 trans-
poson, with the 38 bp inverted repeats together with the 5 bp
direct repeats (5′-GTCCT-3′) of the Tn1546 target site in str,i s
conserved in both plasmids.
The plasmids pIP816 and pVEF4 contain putative CDSs
involved in their own replication and maintenance. The replica-
tion of pIP816 is probably ensured through the replication
protein RepE (CDS17) described in the Inc18 plasmid pAMb1
from E. faecalis.
39 The origin of replication (oriR), copy number
repressor (CopF), and hypothetical proteins ORFC and ORFD of
pAMb1 are also 100% conserved in pIP816 (Table 4). Thus,
pIP816 is predicted to replicate by a DNA polymerase
I-dependent u mechanism, such as pAMb1.
40,41 pVEF4 encodes
a replication protein (CDS24) previously reported in pVEF1 and
pVEF2,
11 and an oriR identical to oriR of pAMb1 is found
downstream of the Rep protein. Recently, Jensen et al.
42 pre-
sented a classiﬁcation system for plasmids from enterococci
and other Gram-positive bacteria based on the conserved
areas of the replication initiation genes (rep). According to this
classiﬁcation system, pIP816 groups into rep families 1 and 2,
whereas pVEF4 is a member of group 1 (but also harbours an
additional rep gene with limited sequence similarity to group
11). The presence of more than one rep gene may indicate
increased host range, and groups 1 and 2 contain strains from
Enterococcus, Staphylococcus and Streptococcus.
Genes involved in site-speciﬁc recombination (resolvases) and
active partition processes of plasmids are found on pIP816 and
pVEF4, putatively contributing to stable inheritance. Thus, the
segregational stability of pIP816 is putatively under the control
of the active partitioning systems delta-omega (d-v), as
described for plasmid pSM19035 from Streptococcus pyogenes,
43
and/or the prgP-prgO gene products as described for pCF10 from
E. faecalis.
44 Complete and fragmented insertion sequences (ISs)
and transposases constitute 21% (n¼8) and 18% (n¼11) of the
DNA sequence of pIP816 and the partial pVEF4, respectively.
Inverted repeats of the IS6 (5′-ggttctgttgcaaagttttaaatctacta
tcaaa-3′)o rI S 30 families (5′-cgccgattgtaaaattaagctagacaaata
-3′) are found along with most of the IS elements.
Comparative analysis of vanA plasmids
A genetic element ( 18 kb) including the non-conjugative
Tn1546 was found conserved between the vanA plasmids
pIP816, pVEF1, pVEF2, pVEF3 and partial pVEF4. An additional
7 kb element, ﬂanked by two IS1216, was present immediately
upstream in pIP816 (inverted), pVEF1, pVEF2 and pVEF3
(Figure 2). Thus, a common conserved genetic fragment of
 25 kb was present in three vanA plasmids with a separate evol-
utionary history over .13 years.
The presence of the conserved 25 kb vanA-containing frag-
ment was further examined among a collection of 28 hetero-
geneous vanA plasmids, as determined by restriction fragment
length polymorphism analyses (data not shown), from genomi-
cally different E. faecium strains of diverse epidemiology and
geographical origin (Table 1). The complete 25 kb fragment
was only present in the completely sequenced pVEF1, pVEF2
and pVEF3. These three plasmids are present in genomically
diverse strains, as previously shown by PFGE.
21 In pVEF1 and
pVEF2, the 25 kb fragment is ﬂanked by IS1216. Parts of the
elements ﬂanking the vanA gene cluster were also found on 15
additional plasmids. Of these, 12 were extracted from
E. faecium strains sampled from Norwegian poultry farms (four
poultry strains and eight poultry farmer strains at six different
timepoints from 1998–2002) and three extracted from clinical
strains (two from Norway and one from Portugal). Available
multilocus sequence typing (MLST) data revealed that the
different strains with intact or parts of the common
Tn1546-containing fragment group into clonal complexes 1, 9,
17 and 22 (Table 1).
DNA sequence alignment of the ampliﬁed plasmid fragments
demonstrates high sequence identity, but a deletion of the d
gene was found for eight plasmids (Figure 2). The 5′ end of
Tn1546 is inverted in pIP816 compared with pVEF1, pVEF2 and
pVEF3, and both gene order patterns are found on other plas-
mids (Figure 2).
Table 2. The completely sequenced vanA plasmids of enterococci as of
May 2010
Plasmid Host strain
Size
(kbp) Reference
Accession
number
pIP816 E. faecium BM4147 34.6 This study AM296544
pVEF1 E. faecium 399/F99/H8 39.6 11 AM410096
pVEF2 E. faecium 399/F99/A9 39.6 11 AM410096
pVEF3 E. faecium 399/S99/A7 63.1 58 AM931300
pHTb
a E. faecium FH 63.7 59 AB183714
aThe vanA plasmid (pHTb) isolated from an E. faecium strain in Japan was
included in the presented analysis. However, no DNA sequence identity
was found, except from the presence of Tn1546.
Table 3. PCR and RT–PCR primers used in the study
Primer Sequence (5′–3′) Binding site or reference
PCF1 AGGGATTCGTCAGGAAAATAGG pVEF1 nt 19439–19460
PCF2 AGCGTGTATGGTTTCAATTCC pVEF1 nt 20705–20685
PCF3 TCTCTTACGATTTTCTCATCCACA pVEF1 nt 26932–26909
PCF4 TCGTGACAATCGGAACTAAAACT pIP816 nt 27553–27575
PCF5 AGTAACAAAGAAAGCCCAATTATCA pVEF1 nt 8748–8724
PCF6 ACTTTTAGTTGGCTTGGACTGAAC pVEF1 nt 2742–2765
giiF TGGAATGATAGGGTAACG Intron (5′ end, forward)
giiF5 TGGTTGCGAGACTTAGGAAAAC Intron (3′ end, forward)
giiR3 AYACGGCGTTCCATCAA Intron (3′ end, reverse)
giiR7 TAAGGTATAAGGTGGGCGTTTG topo (3′ end, reverse)
giiR8 TGTTCTACCCGACACATTTCTG Intron (5′ end, reverse)
ip3F AGACCCACTATTTACAGATG topo (5′ end, forward)
Ent1 TACTGACAAACCATTCATGATG 60
Ent2 AACTTCGTCACCAACGCGAAC 60
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The annotation of the partial pVEF4 from E. faecium 399/F98/A4
identiﬁed a 2770 bp group II intron inserted into the topoisom-
erase I (topo) gene and it was named En.fm.I2 according to
the mobile group II intron database nomenclature.
45 The pre-
dicted secondary RNA structure (Figure 3a) shows that En.fm.I2
displays structural features similar to introns belonging to
the bacterial class B of group II introns. En.fm.I2 carries a puta-
tive intron-encoded protein (IEP) (CDS19, Table 5) located in
domain IV, with domains responsible for the maturase function,
reverse transcriptase function and endonuclease function
(Figure 3b).
To test if the En.fm.I2 is a functional ribozyme and splices in
vivo, total RNA was extracted, and RT–PCR was run with exon–
exon-speciﬁc primers on DNA of pVEF4 and on pVEF3 as a nega-
tive control. En.fm.I2 intron splicing was established (Figure 4,
lane 1) and the ligated exons were conﬁrmed by sequencing
(data not shown). Speciﬁc primers targeting the intron–exon
junctions (both 5′ and 3′) were used in RT–PCR reactions and
conﬁrmed the presence of unspliced intron in pVEF4, but not in
the negative control (pVEF3) (Figure 4). Primers amplifying the
2′–5′ junction allowed the identiﬁcation of the splicing
pathway of En.fm.I2 (Figure 4, lanes 7 and 8). DNA sequencing
of the generated PCR product showed that the En.fm.I2 forms
a lariat structure in vivo with the 5′ end docking into the
bulged A in domain VI.
Distribution of the intron En.fm.I2 in vanA plasmids
Because the topo gene and En.fm.I2 of pVEF4 were found adja-
cent to Tn1546, the wider presence of En.fm.I2 was determined
among the 28 heterogeneous vanA plasmids (Figure 2). In total,
15 En.fm.I2-encoding plasmids were identiﬁed, for which 14 of
the En.fm.I2 introns were found localized in the topo gene. The
intron-positive PCR products were conﬁrmed by sequencing
(data not shown). A highly conserved DNA sequence identity
over the entire intron, including the IEP, was found. Only two
of the En.fm.I2 introns (from E. faecium strains 31/F01/H and
TUH32-79) displayed non-synonymous substitutions in the IEP
protein (Figure 3b).
Feature colour codes:
Resistance
Recombination-associated
Transposable elements
Replication
Stable maintenance
Hypothetical (conserved) proteins
Regulatory
Replication-associated
Surface proteins
Figure 1. Genetic map of pIP816 and pVEF4. Coding regions are represented by arrows indicating the direction of transcription and are coloured
according to their predicted functions. The inverted repeats (IR) of the Tn1546 transposon and the predicted origin of replication (oriR) of the
plasmids are given as black boxes. The group II intron En.fm.I2 of pVEF4 is shown as dark grey boxes ﬂanking the intron-encoding protein. Thin
arrows indicate the 25 kb larger genetic unit. Truncated CDSs are indicated with a prime symbol (e.g. tnp′).
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We present the complete sequence of pIP816, the ﬁrst vanA
plasmid isolated in France 1986, as well as a partial, annotated
sequence of the fourth plasmid isolated from a single Norwegian
poultry farm, pVEF4. The comparative analyses with other com-
pletely sequenced vanA plasmids reveal that pVEF1–pVEF4 share
a common genetic element of  18 kb that spans the entire
Tn1546 transposon, a topoisomerase I (topo) gene and the
genes encoding the active partitioning system d-v of plasmid
pSM19035
43 upstream of the vanA gene cluster. Three shared
CDSs are located downstream of Tn1546.
Surprisingly, an identical (.99% identity at the nucleotide
level) 18 kb fragment is present in pIP816. When the inverted
fragment located upstream is included, the size of the
common fragment present in pIP816, pVEF1, pVEF2 and pVEF3
is  25 kb. The observation that the same plasmid-borne DNA
fragment (harbouring Tn1546) was found on a Norwegian
poultry farm 13 years after the original isolation of pIP816 in a
clinical isolate in France
13 suggests either successful clonal
spread or horizontal transfer between E. faecium strains of differ-
ent origins. As determined by Werner and colleagues,
46 the
pIP816 host BM4147 belongs to the MLST clonal complex (CC)
22, one of three CCs considered to be host-speciﬁc for humans
Table 4. Coding sequences (CDSs) of the circular vanA plasmid pIP816
CDS
a
Protein length
(amino acids) Database match
Amino acid
identity (%)
1 tnp Tn1546 988 pIP816 Tn1546 transposase (Q06238) 100
2 res Tn1546 191 pIP816 resolvase (Q06237) 100
3 vanR 231 pIP816 VanR protein (Q06239) 100
4 vanS 384 pIP816 VanS protein (Q06240) 100
5 vanH 322 pIP816 VanH protein (Q05709) 100
6 vanA 343 pIP816 VanA protein (P25051) 100
7 vanX 202 pIP816 VanX protein (Q06241) 100
8 vanY 303 pIP816 VanY protein (P37711) 100
9 vanZ 161 pIP816 VanZ protein (Q06242) 100
10 str′ 188 N-terminal part of pS194 streptomycin resistance protein, Staphylococcus aureus (P12055) 95
11 tnp′ 176 pLI100 transposase, Listeria innocua (CAC42047) 98
12 v 71 pSM19035 transcriptional repressor v, Streptococcus pyogenes (YP_232757) 100
13 d 298 pIlo8 d protein, Oenococcus oeni (CAD70616) / pSM19035 active partitioning d protein,
S. pyogenes (YP_232765)
100/98
14 topo 714 pAMb1 type 1 topoisomerase, Enterococcus faecalis (AAC38606) 97
15 resIP 205 pGB354 resolvase, Streptococcus agalactiae (AAB48454) 100
16 hcp 56 pRE25 orf7 hypothetical conserved protein, E. faecalis (CAC29163) 100
17 repE 497 pAMb1 RepE replication protein, E. faecalis (Q52249) 100
18 hcp 99 pAMb1 orfD, E. faecalis (Q52248) 100
19 copF 83 pAMb1 copy number repressor, CopF, E. faecalis (Q52247) 100
20 hcp 274 pAMb1 orfC, E. faecalis (Q52246) 100
21 IS1216 228 IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786 and pE418 (e.g. CAC29206) 100
22 IS1252 319 pHKK701 IS1252 transposase (AAB42161) 99
23 res 190 pRE25 orf53 resolvase, E. faecalis (Q9AKZ9) 100
24 ﬁc 201 pRE25 orf52 cell ﬁlament protein, Fic, E. faecalis (Q9AL00) 100
25 Integrase′ 215 Integrase, Enterococcus faecium DO (Q3Y1H6) 81
26 hcp′ 214 Plasmid2 hypothetical protein, Nitrosomonas eutropha C71 (Q3N6Z6) 39
27 IS1216 228 IS1216, E. faecium (Q9KI43) / IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786, pUW1965
and pE418 (e.g. CAC29206)
100/99
28 prgO 91 pRE25 PrgO protein, E. faecalis (Q9AKZ5) 100
29 prgP 317 pRE25 PrgP protein, E. faecalis (Q9AKZ4) 100
30 repE 498 pRE25 ORF1, putative replication protein, E. faecalis (Q9AL28) 100
31 prgN 98 pRE25 PrgN protein, E. faecalis (Q9AL27) 100
32 hcp 283 Hypothetical protein of E. faecium DO (EAN10371) / pRE25 hypothetical protein ORF4,
E. faecalis (Q9AL25)
100/99
33 IS1216 228 IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786 and pE418 (e.g. CAC29206) 100
34 tnp′ 118 pLI100 pLI0071 protein, putative transposase of L. innocua (Q925W6) 85
35 tnp′ 114 pLI100 pLI0020 protein, putative transposase of L. innocua (Q926N5) 87
36 str′ 94 C-terminal part of pS194 streptomycin resistance protein, S. aureus (P12055) 95
aPrime indicates truncated CDS; hcp, hypothetical conserved protein.
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JAC(CC17, CC22 and CC94).
47–49 In contrast, most of the strains
isolated from the Norwegian poultry farms (of both poultry and
farmer origin) belong to CC9, considered to be host-speciﬁc for
poultry (including the hosts of pVEF1 and pVEF2).
47,48 This
observation is consistent with the suggested horizontal transfer
of a mobile genetic unit larger than Tn1546 between different
clonal complexes of E. faecium, although the direction and fre-
quency of transfer is uncertain.
Table 5. Coding sequences (CDSs) of the vanA plasmid pVEF4 (partial)
CDS
a
Protein length
(amino acids) Database match (accession number)
Amino acid
identity (%)
1 hp 135 —
2 tnp′ 118 pVEF2 truncated transposase, C-terminal part (CAL90948) 100
3 tnp′ 114 pVEF1/pVEF2 truncated transposase, N-terminal part (CAL36541/CAL90947) 100
4 str′ 94 pS194 streptomycin resistance protein, Staphylococcus aureus (P12055) 95
5 tnp Tn1546 988 pIP816 Tn1546 transposase (Q06238) 100
6 res Tn1546 191 pIP816 resolvase (Q06237) 100
7 vanR 231 pIP816 VanR protein (Q06239) 100
8 vans 384 pIP816 VanS protein (Q06240) 100
9 vanH 322 pIP816 VanH protein (Q05709) 100
10 vanA 343 pIP816 VanA protein (P25051) 100
11 vanX 202 pIP816 VanX protein (Q06241) 100
12 vanY 303 pIP816 VanY protein (P37711) 100
13 vanZ 161 pIP816 VanZ protein (Q06242) 100
14 str′ 188 pS194 streptomycin resistance protein, S. aureus (P12055) 95
15 tnp′ 176 pVEF1/pVEF2 truncated transposase, C-terminal part (CAL36529/CAL90935) 100
16 v 71 pVEF1/pVEF2 putative transcriptional repressor v (CAL36528/CAL90934) 100
17 d 298 pVEF1/pVEF2 putative d protein (CAL36527/CAL90933) 100
18 topo 715 pVEF1/pVEF2 putative topoisomerase I (CAL36526/CAL90932) 100
19 iep 628 pBc10987 group II reverse transcriptase, Bacillus cereus ATCC 10987 59
20 res 205 pVEF1/pVEF2 putative resolvase (CAL36525/CAL90931) 100
21 hcp 56 pRE25 and pVEF1/pVEF2 hypothetical conserved protein (Q9AL24, CAL36524/CAL90930) 100
22 IS1216′ 82 IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786 and pE418 (e.g. CAC29206) 97
23 prgN 95 pVEF1/pVEF2 putative PrgN protein (CAL36522/CAL90928) 100
24 repE 499 pVEF1/pVEF2 putative replication protein (CAL36521/CAL90927) 100
25 ATPase 303 pVEF1/pVEF2 putative ATPase (CAL36563/CAL90969) 100
26 hcp 123 pVEF1/pVEF2 hypothetical protein (CAL36562/CAL09068) 100
27 IS1216 228 IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786 and pE418 (e.g. CAC29206) 100
28 hcp 121 pIP501 orf7, Streptococcus agalactiae (Q7AYQ0) 100
29 z′ 84 pVEF1/pVEF2 z toxin (CAL36553/CAL90959) 95
30 hcp 196 pVEF1/pVEF2 hypothetical protein (CAL36558/CAL909064) 99
31 permease 537 Putative tetronasin resistance transmembrane protein, Streptococcus pyogenes MGAS10750
(YP_603196)
69
32 ATPase 293 Putative tetronasin resistance ATP-binding protein, S. pyogenes MGAS10750 (YP_603195) 85
33 regR 198 pVEF1/pVEF2 putative regulatory protein, TetR family (CAL36555/CAL90961) 97
34 ltrC 374 pMRC01 low temperature requirement C protein LtrC, Lactococcus lactis (AAC56005) 58
35 IS1216 228 IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786 and pE418 (e.g. CAC29206) 100
36 int 278 Putative integrase, catalytic region, Enterococcus faecium DO (EAN09812) 99
37 IS3/IS911 96 Putative IS3/IS911, E. faecium DO (EAN09811) 100
38 repA′ 137 pEF418 putative replication protein, Enterococcus faecalis (AAL05545) 98
39 IS1216′ 179 IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786 and pE418 (e.g. CAC29206) 100
40 rep′ 172 pEFR putative replication protein, E. faecium (Q8KSS2) 66
41 repB 174 pB82 replication protein RepB, E. faecium (A0JBS1) 49
42 hcp 93 Hypothetical conserved protein, E. faecium DO (EAN10162) 60
43 hcp 138 pEF1 orf33 hypothetical conserved protein, E. faecium 6T1a (A3QN12) 55
44 abiF 258 pNP40 abortive infection bacteriophage resistance protein, L. lactis DRC3 (AAB52386) 53
45 IS1216 228 IS1216 on pRE25, pRUM, pTEF1, pTEF3, pUW786 and pE418 (e.g. CAC29206) 100
46 hp 293 Hypothetical protein —
aPrime indicates truncated CDS; hcp, hypothetical conserved protein; hp, hypothetical protein.
Sletvold et al.
1900Figure 2. Gene organization of Tn1546 and ﬂanking areas in vanA plasmids from genomically different E. faecium strains of human or animal origin.
Identical coding regions are colour-coded to highlight similarities in the Tn1546 ﬂanking regions. Similar colour indicates identity. White, Tn1546; red,
IS1216; dark grey, intron En.fm.I2 and iep. Note that the  7 kbp region ﬂanked by IS1216 (red arrows) in pVEF1–pVEF3 is inverted in pIP816, and that
similar organization was found in plasmids from two GREF from two Norwegian poultry farms (strains 399/F99/A8 and 64/F98/A1). The top line
indicates the size of the aligned Tn1546 ﬂanking regions, with positional marks in kbp.
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JACTn1546 was found inserted into a streptomycin resistance
gene and conserved direct repeats were found in all vanA plas-
mids studied. The majority of these host strains were from
Norwegian poultry farms previously exposed to avoparcin. Avail-
able MLST typing data
22,46,47,50 showed that the different MLST
types clustered into CC9. These data further extend previous
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Figure 3. Structural features of En.fm.I2 and its intron-encoded protein (IEP). (a) Predicted secondary RNA structure of En.fm.I2. Intron nucleotides are
written in capital letters and exon sequences are written in lowercase letters. Roman numerals denote the domains I–VI. The IEP is found in domain
IV. Intron-binding sites (IBSs) 1 and 2 along with the exon-binding sites (EBSs) 1 and 2 are marked by arrows and boxes, respectively. IBS/EBS3 is a
single nucleotide interaction and denoted by pointing arrows. The bulged A (branch site) is located in domain VI and shown in bold. (b) The putative
IEP displays a reverse transcriptase (RT) domain (bold letters), a maturase (X) domain (italics) and an endonuclease (En) domain (grey). All introns
analysed, except two, had identical amino acid composition to En.fm.I2 of pVEF4 (no. 54, top). The non-synonymous substitutions in En.fm.I2
from E. faecium strains 31/F01/H (no. 49) and TUH32-79 (no. 45) are shown in the alignment (identical amino acids are represented by a dot; a
dash indicates gaps or substitutions).
Sletvold et al.
1902reports of the successful spread of a common plasmid-mediated
genetic element surrounding Tn1546 on Norwegian poultry
farms.
21,22 Our observation is also consistent with the original
pIP816 characterization with respect to insertion junctions,
23
and a recent Tn1546 junction fragment analysis of E. faecium
strains from the UK, Denmark, the Netherlands and Norway;
51
presenting evidence of the geographical distribution of two
different Tn1546–plasmid insertion junctions. Garcia-Migura
et al.
51 hypothesize that a common genetic element has
spread across different clonal lines within the European broiler
sector. The data presented here shed light on the composition
and size of this element. Moreover, our data also suggest
genetic interactions between E. faecium in animal reservoirs
and CC17, the only E. faecium clinical high-risk CC.
47,49 Strain
TUH32-76, a clinical CC17 GREF isolate from Portugal, displays
Tn1546 insertion in the streptomycin resistance gene and two
immediately adjacent CDSs are linked to the 5′ end of the vanA
gene cluster.
Tn1546 belongs to the non-conjugative class II transposable
elements of the Tn3 family
52 and transfers intracellularly by
replicative transposition to diverse sites.
23 Thus, the expected
transfer by replicative transposition is inconsistent with the
genetic patterns observed ﬂanking the Tn1546 transposon
reported here and elsewhere.
51 Our data, as well as previous
experimental results,
23 do not support the hypothesis that the
streptomycin resistance gene represents a hotspot for Tn1546
integration.
A detailed look at the plasmid sequences analysed here
reveals that IS1216 is present in one or both ﬂanking regions
of the larger glycopeptide resistance-encoding region (of 18–
25 kb), suggesting movement of Tn1546 as part of a composite
transposon. Composite transposons are well known to mobilize
antibiotic resistance genes in enterococci, e.g. Tn5281 ﬂanked
by IS256,T n 1547 ﬂanked by IS16- and IS256-like elements,
and Tn5385 ﬂanked by IS1216.
8,9,53 Composite transposition
enabled by the IS1216 elements ﬂanking the vanA operon has
5¢exon
3¢exon
Ligated exons
Splice site
Sequence of ligated exons
L
bp
1000
500
100
12 3 45 67 8 9 1 0 L
Figure 4. RT–PCR analyses of the topoisomerase, intron, intron splicing products and enterococcal elongation factor. RT–PCR products from pVEF4
and pVEF3 are given on alternate lanes 1–10. PCR products are shown as follows: topo mRNA without intron (lanes 1 and 2, primer pair ip3F/
giiR7); 5′ intron–exon junction (lanes 3 and 4, primer pair ip3F/giiR8); 3′ intron–exon junction (lanes 5 and 6, primer pair giiF5/giiR7); intron lariat
structure (lanes 7 and 8, primer pair giiF5/giiR8); and positive RT–PCR control (lanes 9 and 10, primer pair Ent1/Ent2). Ladder (lanes L), 100 bp
DNA molecular size marker from New England Biolabs. The sequence data of the ligated exon with the indicated splice site is shown in the lower
half of the ﬁgure.
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JACalso previously been described.
54 The authors showed that
IS1216 elements facilitated the transfer of Tn1546 from a non-
conjugative plasmid to a pheromone-responsive conjugative
plasmid present in the same enterococcal cell, with subsequent
intercellular transfer of the vanA gene cluster.
The broader comparative analysis of the genetic composition
and gene order (synteny) of pIP816 and the pVEF-type vanA
plasmids reveals multiple copies of plasmid replication and
maintenance genes interspersed with several copies of IS
elements. The mosaic plasmid structures indicate frequent for-
mations of plasmid hybrids, recombination and transposition
events. Interestingly, no known conjugal transfer genes have
been found in any of the completely sequenced vanA plasmids
from Norwegian poultry farms. This, however, does not mean
that the plasmids or parts of them are constrained to a single
strain. Plasmid co-transfer by the conjugative transposon
Tn916 has been reported in enterococci.
55 Conjugative mobiliz-
ation of enterococcal plasmids has also been reported.
5,10
The sequence comparison of the E. faecium vanA plasmids
enabled the discovery of the novel group II intron En.fm.I2
inserted into the topo gene of pVEF4. Mobile genetic group II
intron elements are commonly found in bacteria, although
they are not well characterized in enterococci.
45 The intron
En.fm.I2 belongs to the group II bacterial class B introns, has
an IEP that displays features of a multifunctional protein that
might enable its mobility and follows the standard group II
intron splicing pathway.
28 Bacterial mobile group II introns
are generally site-speciﬁc on insertion and rapidly spread
horizontally.
56 However, vanA plasmids encoding intron-free
topo genes were detected in E. faecium strains (64/F98/H2 and
64/F98/H1) of human origin (one farmer) sampled at one
poultry farm on the same occasion, where both plasmids are
topo-encoding but only one is invaded by En.fm.I2.
In conclusion, comparative analysis of the original vanA
plasmid pIP816 with the recently sequenced pVEF-type plasmids
revealed a conserved genetic fragment (including Tn1546)o f
18–25 kb. Taken together, the data show that VanA-type glyco-
peptide resistance is present in different clonal complexes of
E. faecium and suggests that glycopeptide resistance can be dis-
seminated through IS1216-facilitated composite transposition.
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